Renal Biopsy Unexplained Elevated Serum Creatinine
Renal Biopsy Findings In Patients With Unexplained Elevated Serum Creatinine In Assiut University Hospital
1 other identifier
observational
210
1 country
1
Brief Summary
Patients presented with unexplained elevated serum creatinine including vast varieties of acute or chronic kidney disease. Renal biopsy may include acute and chronic interstitial nephritis, glomerulosclerosis and tubular atrophy, acute tubular necrosis, rapidly progressive glomerulonephritis, granulomatous glomerulonephritis, monoclonal gammopathy, myeloma kidney or thrombotic microangiopathy . Renal biopsy definitely still plays the most vital and irreplaceable role in the investigations of cases with unexplained renal impairment. Despite a vastly variable biopsy results between patients, renal biopsy has helped in determining the best treatment and prognosis for the patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 13, 2018
CompletedFirst Submitted
Initial submission to the registry
June 19, 2018
CompletedFirst Posted
Study publicly available on registry
July 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedJuly 19, 2023
July 1, 2023
3 years
June 19, 2018
July 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
correlation between histopathological findings and serum creatinine in umol/l
histopathological patterns in term of glomerlular pathology, interstitial fibrosis, tubular injury and serum creatinine in umol /l
3 years
Interventions
Renal biopsy samples will be obtained by a percutaneous method using a spring-loaded Trucut® biopsy needle under real time ultrasound guidance. Biopsy samples will be processed for light microscopy with special staining will be done: Schiff periodic acid, Masson trichrome and methenamine silver.and immunofluorescence studies to evaluate IgA, IgG, IgM, complement C1q and C3, fibrin, and kappa and lambda light chain deposits.
Eligibility Criteria
patients attended to outpatient clinics or admitted to internal medicine department in assiut univesity hospital
You may qualify if:
- Impaired renal function (serum creatinine\> 115umol/l serum urea \> 8 mmol/l)
- Negative immunological markers i.e ANA, ANCA, cryoglobulin, and complement level.
You may not qualify if:
- Diabetic patients.
- Hypertensive patients.
- All causes of Acute kidney injury
- Bleeding diathesis.
- Known cases of primary or secondary glomerulonephritis.
- Patients with a single functioning kidney
- small sized kidneys
- Multiple renal cysts and ADPKD.
- Patients with asymmetrical kidney size.
- Patient with active infections.
- HBsAg, HCV and HIV positive patients.
- Obstructive uropathy.
- Patients with active malignancies e.g multiple myeloma
- Renal transplant.
- Refusal to do a biopsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University Hospital
Asyut, 71515, Egypt
Related Publications (1)
Ellisy RA, Tony EA, Ismail W, Radi R, Seddik MI, Abdel Aziz EM. Clinicopathological characteristics and outcomes of patients with unexplained renal impairment: A single center study. Nefrologia (Engl Ed). 2025 Mar;45(3):249-258. doi: 10.1016/j.nefroe.2025.02.012.
PMID: 40082054DERIVED
Biospecimen
Renal biopsy spicemin retained in diluted formaldyde
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
June 19, 2018
First Posted
July 13, 2018
Study Start
June 13, 2018
Primary Completion
May 31, 2021
Study Completion
May 1, 2022
Last Updated
July 19, 2023
Record last verified: 2023-07